Callitas Health die alte M Pharmaceutical (Seite 5)
eröffnet am 22.09.17 16:18:40 von
neuester Beitrag 28.05.22 09:19:31 von
neuester Beitrag 28.05.22 09:19:31 von
Beiträge: 426
ID: 1.262.481
ID: 1.262.481
Aufrufe heute: 0
Gesamt: 73.087
Gesamt: 73.087
Aktive User: 0
ISIN: CA13125C1068 · WKN: A2GSU1 · Symbol: MPHMF
0,0001
USD
+9.900,00 %
+0,0001 USD
Letzter Kurs 02.03.24 Nasdaq OTC
Werte aus der Branche Pharmaindustrie
Wertpapier | Kurs | Perf. % |
---|---|---|
0,9998 | +169,42 | |
9,0000 | +116,87 | |
16,240 | +34,55 | |
1,0000 | +33,33 | |
15,348 | +19,53 |
Wertpapier | Kurs | Perf. % |
---|---|---|
6.059,00 | -15,16 | |
5,2500 | -19,23 | |
5,2300 | -20,64 | |
0,7800 | -29,73 | |
122,80 | -33,44 |
Beitrag zu dieser Diskussion schreiben
wieso kann man in Amerika handeln? (27.09.2019-5000st)
ist das was eigenständiges im amiland?
ist das was eigenständiges im amiland?
Bin zum Glueck raus, hatte mich erst geaergert.
Hat einer Infos wie oder ob das Ding jemals wieder Handeln kann. Der Kurs steht auf 0,1
Antwort auf Beitrag Nr.: 61.363.316 von allin123 am 28.08.19 18:42:48Ja so ist es bin noch in sirona und aeterna drin hoffe komm mit einem blauen auge davon, der cad dreck kommt mir nicht mehr ins depot.
Antwort auf Beitrag Nr.: 61.363.058 von Muckimann66 am 28.08.19 18:09:26glaub, bei 99% aller CAD-Werte kann man die Kohle abschreiben...
siehe auch https://www.wallstreet-online.de/diskussion/1200091-1-10/
siehe auch https://www.wallstreet-online.de/diskussion/1200091-1-10/
Antwort auf Beitrag Nr.: 61.362.989 von allin123 am 28.08.19 17:59:12Hoffe nicht hab die verloren Kohle schon abgeschrieben. Schlimm wenn noch andere auf solche Firmen reinfallen.
ob die Gurke jemals wieder online geht!?
The company confirms that there are no insolvency proceedings against it as of the date of this press release.
wenn die das schon so explizit erwähnen, weisst Bescheid
wenn die das schon so explizit erwähnen, weisst Bescheid
...und täglich grüsst filing delay Tier...Scheint ihre neue Lieblingsbeschäftigung zu sein (was anderes kriegen die ja nicht auf die Reihe). Wird dann wieder einen monatelangen Tradehalt geben...tss....was für ein absoluter Saftladen
Callitas to delay filing annual financial statements
2019-05-01 10:21 ET - News Release
Mr. James Thompson reportsCALLITAS HEALTH ANNOUNCES LATE FILING OF ANNUAL FINANCIAL DISCLOSURECallitas Health Inc.'s filing of its audited annual financial statements, management's discussion and analysis, and related chief executive officer and chief financial officer certifications for the financial year ended Dec. 31, 2018, will be delayed beyond the filing deadline of April 30, 2019. The delay in the completion of the required filings is a result of the resignation of BDO Canada LLP as the auditors of the company on April 9, 2019.The company has made an application to the British Columbia Securities Commission for a management cease trade order, which would restrict all trading in securities of the company, whether direct or indirect, by management of the company. The MCTO would not affect the ability of shareholders who are not insiders of the company to trade their securities. There is no certainty that the MCTO will be granted. If the MCTO is not issued by the BCSC, the applicable Canadian securities regulatory authorities could issue a general cease trade order against the company for failure to file the required filings within the prescribed time period.The company is working expeditiously with its successor auditor, Marcum LLP, to complete the audit as soon as possible. Callitas expects the required filings to occur prior to July 2, 2019. The company also intends to satisfy the provisions of the alternate information guidelines of Section 10 of National Policy 12-203 -- Management Cease Trade Orders -- as long as it is in default of the filing requirements.The company confirms that there are no insolvency proceedings against it as of the date of this press release. The company also confirms that there is no other material information concerning the affairs of the company that has not been generally disclosed as of the date of this press release.About Callitas Health Inc.Callitas is a clinical-stage pharmaceutical development, over-the-counter consumer goods marketing and cannabis delivery development company, focused on developing innovative technologies for weight management, female sexual health and wellness, cannabis delivery technologies, and other proprietary drugs.
Callitas to delay filing annual financial statements
2019-05-01 10:21 ET - News Release
Mr. James Thompson reportsCALLITAS HEALTH ANNOUNCES LATE FILING OF ANNUAL FINANCIAL DISCLOSURECallitas Health Inc.'s filing of its audited annual financial statements, management's discussion and analysis, and related chief executive officer and chief financial officer certifications for the financial year ended Dec. 31, 2018, will be delayed beyond the filing deadline of April 30, 2019. The delay in the completion of the required filings is a result of the resignation of BDO Canada LLP as the auditors of the company on April 9, 2019.The company has made an application to the British Columbia Securities Commission for a management cease trade order, which would restrict all trading in securities of the company, whether direct or indirect, by management of the company. The MCTO would not affect the ability of shareholders who are not insiders of the company to trade their securities. There is no certainty that the MCTO will be granted. If the MCTO is not issued by the BCSC, the applicable Canadian securities regulatory authorities could issue a general cease trade order against the company for failure to file the required filings within the prescribed time period.The company is working expeditiously with its successor auditor, Marcum LLP, to complete the audit as soon as possible. Callitas expects the required filings to occur prior to July 2, 2019. The company also intends to satisfy the provisions of the alternate information guidelines of Section 10 of National Policy 12-203 -- Management Cease Trade Orders -- as long as it is in default of the filing requirements.The company confirms that there are no insolvency proceedings against it as of the date of this press release. The company also confirms that there is no other material information concerning the affairs of the company that has not been generally disclosed as of the date of this press release.About Callitas Health Inc.Callitas is a clinical-stage pharmaceutical development, over-the-counter consumer goods marketing and cannabis delivery development company, focused on developing innovative technologies for weight management, female sexual health and wellness, cannabis delivery technologies, and other proprietary drugs.
Antwort auf Beitrag Nr.: 60.274.404 von Greenhorn_3 am 04.04.19 10:28:20
Hier nochmal der Link zu anklicken
https://www.wallstreet-online.de/aktien/empower-clinics-akti…